Spyre Therapeutics

  • BioTech/Drugs
  • Waltham MA
  • 63 employees
Get Full Info

Company Overview

Website
spyre.com
Employees
63
Founded in
2023
Industry
BioTech/Drugs
More Details

Financials & Stats

Revenue

$10B

More Financials

Recent News & Media

Spyre Therapeutics, Inc. (SYRE) Stock Analysis: High Growth Potential With A 242% Upside

  • Jul 4, 2025
  • directorstalkinterviews.com

Spyre Therapeutics Announces Grants of Inducement Awards

  • Jul 3, 2025
  • globenewswire.com

Spyre Therapeutics Announces Grants of Inducement Awards

  • Jul 3, 2025
  • wjhl.com

Spyre Therapeutics Announces Positive Interim Phase 1 Results for Two Next-Generation TL1A Antibody Programs, and Provides Clinical Development Updates Expected to Deliver 9 Phase 2 Readouts

  • Jun 17, 2025
  • prnewswire.com

Spyre Therapeutics to Host Conference Call and Webcast to Report Interim Results from Phase 1 Healthy Volunteer Trials for its SPY002 Program, its Novel Half-Life Extended Anti-TL1A Antibodies on June 17, 2025

  • Jun 17, 2025
  • prnewswire.com

Spyre Therapeutics to Unveil First Human Trial Data for Revolutionary IBD Antibody Treatment

  • Jun 16, 2025
  • stocktitan.net

Who is Spyre Therapeutics

Spyre Therapeutics is a biotechnology company based in Waltham, Massachusetts. Employing 63 people, the company is focused on developing innovative treatments for inflammatory bowel disease. Spyre Therapeutics specializes in a multi-pronged approach to treating inflammatory bowel disease, utilizing advanced antibody engineering, strategic therapeutic combinations, and precise immunology methodologies. Their goal is to create treatments that are not only highly effective but also prioritize patient safety and convenience. The company's commitment to cutting-edge research and development sets them apart in the field. By integrating diverse scientific disciplines, Spyre Therapeutics aims to deliver transformative therapies that significantly improve the lives of patients suffering from inflammatory bowel disease. For more information about Spyre Therapeutics and their groundbreaking work, please visit their website at spyre.com.

Company Leadership

Melissa Cooper

SVP, People

Phone Email
Andy Spencer

SVP, Preclinical Research & Development

Phone Email
Joshua Friedman

SVP, Clinical Development

Phone Email
Deanna Nguyen

SVP, Clinical Development

Phone Email
Eric McIntyre

VP of Finance and Investor Relations

Phone Email

Spyre Therapeutics Industry Tags

Biotechnology Research
View All Industry Tags

Companies Similar to Spyre Therapeutics

Analyze industry trends and opportunities by examining competitors and companies comparable to Spyre Therapeutics, including their performance metrics, financials, growth dynamics, and competitive benchmarks.

Company Name Revenue Number of Employees Location Founded in
10M 59 Boston, MA
10M 27 Cambridge, MA 2010
10M 23 Waltham, MA 1999
10M 2 Boston, MA
10M 46 Woburn, MA
View More Companies

FAQ

What is the location of Spyre Therapeutics's headquarters?
The headquarters of Spyre Therapeutics are situated at 221 Crescent Street, Suite 105, Waltham MA
What is Spyre Therapeutics's official website?
The official website of Spyre Therapeutics can be found at spyre.com.
What is Spyre Therapeutics's current revenue?
As of October 2024, Spyre Therapeutics's annual revenue reached $10B.
How many employees does Spyre Therapeutics currently have?
Spyre Therapeutics employs approximately 63+ people as of October 2024
Which industries is Spyre Therapeutics primarily operating in?
Spyre Therapeutics operates in the following industries: Biotechnology, Pharmaceutical, Therapeutics
Who is the SVP, People of Spyre Therapeutics?
Spyre Therapeutics's SVP, People is Melissa Cooper
What are Spyre Therapeutics's industry tags?
Spyre Therapeutics's industry tags include: Biotechnology Research
When was Spyre Therapeutics founded?
Spyre Therapeutics was founded in 2023.

Employee Directory

Key Employees

Cameron Turtle

Chief Executive Officer

Phone Email

Ivan Noches

VP, Information Technology

Phone Email

Mike Kennedy

Sr. Director, DMPK, Non-Clinical

Phone Email

Anjali Gaspar

Administration and Operations

Phone Email